The enhancement of antitumor antibody binding to cross reactive normal tissue antigens. A complement-mediated effect.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4738048)

Published in Transplantation on September 01, 1973

Authors

W P Drake, M R Mardiney

Articles by these authors

Bacterial proliferation in platelet products stored at room temperature. Transfusion-induced Enterobacter sepsis. N Engl J Med (1971) 1.49

The ubiquitous occurrence of immune complex localization in the renal glomeruli of normal mice. Lab Invest (1973) 1.42

Ultrastructural localization of the third and fourth components of complement on complement-cell complexes. Am J Pathol (1968) 1.39

Nephrotoxic serum nephritis in complement intact and deficient mice. J Immunol (1967) 1.33

Immune complex disease in the kidneys of lymphoma-leukemia patients: the presence of an oncornavirus-related antigen. J Natl Cancer Inst (1973) 1.23

Immunology and morphology of acute post-streptococcal glomerulonephritis. Lab Invest (1966) 1.22

Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease. Am J Med (1977) 1.22

Subclinical immune complexes in the glomeruli of kidneys postmortem. Am J Med (1974) 1.21

The in vitro transformation of frozen-stored lymphocytes in the mixed lymphocyte reaction and in culture with phytohemagglutinin and specific antigens. J Exp Med (1970) 1.19

Postinfectious leukoencephalitis complicating Mycoplasma pneumoniae infection. Arch Neurol (1983) 1.12

Reactivity of human lymphocytes to autologous and homologous serum. J Immunol (1969) 1.04

The vascular pathology of thrombotic thrombocytopenic purpura. An immunohistochemical and ultrastructural study. Lab Invest (1966) 1.03

The demonstration of cell-associated immunity to viruses. In vitro lymphocyte responsiveness to Varicella-zoster antigen. J Immunol Methods (1976) 0.99

The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation. Cell Immunol (1973) 0.98

Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol (1984) 0.98

The characteristics of lymphocyte tritiated thymidine incorporation in response to mumps virus. Cell Immunol (1972) 0.96

Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody. J Natl Cancer Inst (1972) 0.95

Isolation of leukemic blasts from peripheral blood by density gradient centrifugation. J Lab Clin Med (1970) 0.95

Cell-associated immunity to measles (rubeola). The demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measels complement fixation antigen. Cell Immunol (1975) 0.94

Preservation of cellular antigenicity of tumor cells by the use of formalin fixation. Cancer Res (1972) 0.92

Immune complexes localized in the renal glomeruli of AKR mice: the presence of MuLV gs-I and C-type RNA tumor virus gs-3 determinants. Rev Eur Etud Clin Biol (1973) 0.92

The effect of synthetic polynucleotides on immunologically induced tritiated thymidine incorporation. Amplification of response. Transplantation (1972) 0.90

Subclinical immune complex nephritis in patients with Hodgkin's disease. Cancer Res (1974) 0.89

Abnormal profile of human nucleolytic activity as a test for cancer. J Natl Cancer Inst (1975) 0.88

Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma. Cancer Res (1976) 0.87

Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola). Cell Immunol (1975) 0.86

Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro. Cancer Treat Rep (1976) 0.84

A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol (1980) 0.84

In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3. J Immunol Methods (1974) 0.83

A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol (1980) 0.83

Experience with a mixed lymphocyte-tumor reaction as a method of detecting antigenic differences between normal and neoplastic cells. J Immunol (1970) 0.83

The immunosuppressive effect of amantadine upon the response of lymphocytes to specific antigens in vitro. Transplantation (1971) 0.82

A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever. J Allergy Clin Immunol (1982) 0.82

Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion (1974) 0.82

Purification of human lymphocytes by simple centrifugation. Rev Eur Etud Clin Biol (1970) 0.82

Alteration of human serum ribonuclease activity in malignancy. CRC Crit Rev Clin Lab Sci (1978) 0.82

Transformation of mouse lymphocytes to allogeneic lymphocytes and phytohemagglutinin. J Immunol (1970) 0.81

Restoration of the reactivity of frozen stored human lymphocytes in the mixed lymphocyte reaction and in response to specific antigens. Transplantation (1972) 0.81

The role of the human granulocyte as an antigen in the mixed lymphocyte reaction: the lack of stimulation. Transplantation (1972) 0.81

Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice. J Natl Cancer Inst (1973) 0.81

Formalin-fixed cell preparations as standards for use in the automated trypan blue cytotoxic assay. Transplantation (1972) 0.80

Complexing Rauscher leukemia virus reverse transcriptase with human plasma ribonuclease from Hodgkin's disease patients. J Biol Chem (1977) 0.80

Parameters for effective use of synthetic double stranded polynucleotides in the amplification of immunologically induced lymphocyte tritiated thymidine incorporation. Cell Immunol (1974) 0.80

Mycoplasma contamination of membrane associated measles antigens. Inability to demonstrate in vitro lymphocyte responsiveness to measles. Cell Immunol (1975) 0.79

Passive administration of antiserum and complement in producing anti-EL4 cytotoxic activity in the serum of C57BL-6 mice. J Natl Cancer Inst (1973) 0.79

Antibody response in patients with acute nonlymphocytic leukemia. Cancer (1976) 0.79

Sensitivity of mixed lymphocyte reaction and its correlation with skin graft survival. Transplant Proc (1971) 0.78

Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response. J Natl Cancer Inst (1973) 0.78

Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice. Cancer Res (1975) 0.76

The measurement and manipulation of hemolytic complement levels in tumor bearing C57BL/6 mice. Biomedicine (1973) 0.76

Suppression of in vitro lymphocyte responsiveness to purified protein derivative by measles virus. A reexploration of the phenomenon. Cell Immunol (1975) 0.76

The mixed lymphocyte reaction. Detection of single histocompatibility loci and the correlation to skin graft survival in mice. Transplantation (1971) 0.76

Binding studies concerning the interaction of radiolabeled sodium chromate with EL4 leukemia. Transplantation (1972) 0.75

Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapy. Cancer Res (1975) 0.75

Elevated ribonuclease activity in the thymus and white blood cells of genetically cancer prone mice. J Exp Med (1975) 0.75

In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death. Biomedicine (1976) 0.75

Positive long-acting thyroid stimulator response in the complement-deficient mouse. Endocrinology (1967) 0.75

Alteration of the specificity of antitumor antisera by the use of passively administered antibody. Cancer Res (1972) 0.75

Parameters of serum complement in relation to tumor therapy. Biomedicine (1974) 0.75

Quantitative and qualitative analysis of human lymphocyte proliferation to specific antigen in vitro by use of the helium neon laser. J Immunol Methods (1977) 0.75

The dependence of successful immunotherapy on adequate tumor burden as shown by the treatment of AKR leukemia with poly A-poly U. J Natl Cancer Inst (1975) 0.75

The correlation of PHA induced polyamine changes in human lymphocytes with tritiated thymidine incorporation. Biomedicine (1974) 0.75

Complement-mediated alteration of antibody specificity in vivo. J Immunol (1975) 0.75

Augmentation of antitumor antisera activity by lyophilization. J Natl Cancer Inst (1973) 0.75

Immunoprophylaxis and treatment of leukemia in AKR mice: repetitive use of BCG. Natl Cancer Inst Monogr (1973) 0.75

In vitro discordance between actual lymphocyte proliferation and thymidine incorporation on exposure of human lymphocytes to specific antigen or allogeneic cells. Transplant Proc (1977) 0.75

When a commensal becomes a pathogen. Sarcoidosis Vasc Diffuse Lung Dis (2008) 0.75

The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR mice. Cancer Res (1976) 0.75

Differences in potentiation of melanoma growth by absorbable and nonabsorbable suture. J Surg Oncol (1976) 0.75

A current methodology for performing murine mixed lymphocyte reactions. Biomedicine (1973) 0.75

The prevention of clumping of frozen-stored leukocyte populations by EDTA. Cryobiology (1972) 0.75

Latent homology of murine lymphoid antigens revealed through the complement mediated absorption of xenogeneic antiserum. Biomedicine (1976) 0.75

The kinetics of the interaction of heterologous anti-tumor serum and heterologous complement in non-tumor bearing mice. Biomedicine (1975) 0.75

The effects of adrenergic agonists and blockers on antigen-induced DNA synthesis in vitro. Biomedicine (1977) 0.75

A proper sequence for the treatment of B16 melanoma: chemotherapy, surgery, and immunotherapy. J Natl Cancer Inst (1976) 0.75

Comparative effects of different polynucleotide complexes on the immune response of human peripheral blood lymphocytes. Transplantation (1976) 0.75

The formalinization of antibody to tumor cells in altering the immune response. Cancer Res (1972) 0.75

A white blood cell RNase assay for the possible monitoring of malignancy. J Natl Cancer Inst (1975) 0.75

The synergistic effect of synthetic polynucleotides and mercaptoethanol in amplifying the murine mixed lymphocyte reaction. Transplantation (1976) 0.75

Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid. J Natl Cancer Inst (1974) 0.75

Depression of complement activity in tree strains of mice after tumor transfer. Int J Cancer (1973) 0.75

Application of laser cytometry to the analysis of immunologically induced in vitro lymphocyte responsiveness. Transplantation (1977) 0.75

Transformation response of frozen-stored chronic lymphocytic leukemia cells: a preliminary report. Rev Eur Etud Clin Biol (1971) 0.75

A new apparatus for BCG scarification. J Natl Cancer Inst (1975) 0.75

Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma. J Natl Cancer Inst (1978) 0.75

The effect of synthetic polyribonucleotides on EL-4 lymphoma. J Reticuloendothel Soc (1975) 0.75

An improved system for controlled rate cooling of biological material. Cryobiology (1972) 0.75

Immunotherapy for leukemia: quantitative aspects and adjuvant relationships to chemotherapy. Cancer Chemother Rep (1969) 0.75